OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β
Alexis Paulina Jiménez‐Uribe, Tania Gómez‐Sierra, Omar Emiliano Aparicio‐Trejo, et al.
Cellular Signalling (2021) Vol. 87, pp. 110123-110123
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 253

Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets
Allison B. Reiss, Berlin Jacob, Aarij Zubair, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1881-1881
Open Access | Times Cited: 18

Beneficial Effects of Green Tea EGCG on Skin Wound Healing: A Comprehensive Review
Fa-Wei Xu, Ying-Li Lv, Yu‐Fan Zhong, et al.
Molecules (2021) Vol. 26, Iss. 20, pp. 6123-6123
Open Access | Times Cited: 73

Is the Macrophage Phenotype Determinant for Fibrosis Development?
L Lis-López, C Bauset, Marta Seco-Cervera, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1747-1747
Open Access | Times Cited: 69

Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress
Mehdi Sanati, Amir R. Afshari, Prashant Kesharwani, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 287-304
Closed Access | Times Cited: 56

Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2
Boushra Bathish, Holly Robertson, John Dillon, et al.
Free Radical Biology and Medicine (2022) Vol. 188, pp. 221-261
Open Access | Times Cited: 51

Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis
Li Li, Meizhi Lu, Yiling Peng, et al.
Redox Biology (2023) Vol. 67, pp. 102868-102868
Open Access | Times Cited: 30

Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis
Alexandrine Foucault‐Bertaud, Ahmad Joshkon, Xavier Heim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1756-1756
Open Access | Times Cited: 24

Kidney fibrosis: Emerging diagnostic and therapeutic strategies
Barbara M. Klinkhammer, Peter Boor
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101206-101206
Closed Access | Times Cited: 24

Lapatinib ameliorates skin fibrosis by inhibiting TGF-β1/Smad and non-Smad signaling pathway
Yongping Wang, Tiantian Zhang, Hao Song, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs
Karla Rubio, Alejandro Molina-Herrera, Andrea Pérez-González, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12302-12302
Open Access | Times Cited: 19

Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions
Hiromichi Sato, Tomoaki Hara, Sikun Meng, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3487-3495
Open Access | Times Cited: 17

Radiation‐induced fibrosis: Mechanisms and therapeutic strategies from an immune microenvironment perspective
Mengting Zheng, Zhonglong Liu, Yue He
Immunology (2024) Vol. 172, Iss. 4, pp. 533-546
Open Access | Times Cited: 7

Gene therapy with AAV9‐SGPL1 in an animal model of lung fibrosis
Aritra Bhattacharyya, Ranjha Khan, Joanna Y. Lee, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 1, pp. 22-31
Open Access | Times Cited: 5

Research progress on the pathogenesis and prediction of pneumoconiosis among coal miners
Wenlu Hang, Chunlu Bu, Yuming Cui, et al.
Environmental Geochemistry and Health (2024) Vol. 46, Iss. 9
Closed Access | Times Cited: 5

Sesquiterpenoid-Chromone Heterohybrids from Agarwood of Aquilaria sinensis as Potent Specific Smad3 Phosphorylation Inhibitors
Xiaoling Huang, Ye‐Ting Zhou, Yong‐Ming Yan, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 12, pp. 7643-7648
Closed Access | Times Cited: 20

Exploring the therapeutic potential of leriodenine and nuciferine from Nelumbo nucifera for renal fibrosis: an In-silico analysis
Rushendran Rapuru, Rukaiah Fatma Begum, S. Ankul Singh, et al.
Zeitschrift für Naturforschung C (2025)
Closed Access

Stabilisation of extracellular matrix is crucial to rapamycin-mediated life span increase in Marfan mgR/mgR mice
Marcin Zaradzki, Franziska Rehberg, Vanessa I. T. Zwaans, et al.
Biochemical Pharmacology (2025) Vol. 235, pp. 116830-116830
Closed Access

Chicken Primordial Germ Cells Do Not Proliferate in Insulin-Lacking Media
Xin Liu, Jun Wu, Yixiu Peng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3122-3122
Open Access

Runt-related transcription factors: from pathogenesis to therapeutic targets in multiple-organ fibrosis
Feng Yuan, Tianshi Mao, Jing‐Rui Yi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Protective effects and mechanisms of cynaroside on renal fibrosis in mice with unilateral ureteral obstruction
Ah Young Yang, Jung-Yeon Kim, Mi‐Gyeong Gwon, et al.
Redox Report (2025) Vol. 30, Iss. 1
Open Access

Role of macrophage ATP metabolism disorder in SiO2‑induced pulmonary fibrosis: a review
Huijie Hu, Yuanyuan Fu, Shu‐ling Du, et al.
Purinergic Signalling (2025)
Closed Access

Deacetylase‐dependent and ‐independent role of HDAC3 in cardiomyopathy
Jieyu Ren, Qun Zeng, Hongmei Wu, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 3, pp. 647-658
Open Access | Times Cited: 9

Palmatine alleviates cardiac fibrosis by inhibiting fibroblast activation through the STAT3 pathway
Shaoling Lin, Shengxi Zhang, Angyu Zhan, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176395-176395
Closed Access | Times Cited: 3

Irisin ameliorates D-galactose-induced skeletal muscle fibrosis via the PI3K/Akt pathway
Yaoxuan Wu, Yongxin Wu, Jing Yu, et al.
European Journal of Pharmacology (2022) Vol. 939, pp. 175476-175476
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top